Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network

[1]  M S Buchsbaum,et al.  Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia. , 1982, Archives of general psychiatry.

[2]  C. Markham,et al.  Cerebral metabolism and atrophy in huntington's disease determined by 18FDG and computed tomographic scan , 1982, Annals of neurology.

[3]  R. Hichwa,et al.  Positron emission tomographic scan investigations of Huntington's disease: Cerebral metabolic correlates of cognitive function , 1988, Annals of neurology.

[4]  Mario F. Mendez,et al.  Neurobehavioral changes associated with caudate lesions , 1989, Neurology.

[5]  P. Goldman-Rakic,et al.  New frontiers in basal ganglia research , 1990, Trends in Neurosciences.

[6]  A. Graybiel.  Neurotransmitters and neuromodulators in the basal ganglia , 1990, Trends in Neurosciences.

[7]  S. Heckers,et al.  Cortex, white matter, and basal ganglia in schizophrenia: A volumetric postmortem study , 1991, Biological Psychiatry.

[8]  D L Braff,et al.  Magnetic resonance imaging abnormalities in lenticular nuclei and cerebral cortex in schizophrenia. , 1991, Archives of general psychiatry.

[9]  L. Heimer,et al.  "Perestroika" in the basal forebrain: opening the border between neurology and psychiatry. , 1991, Progress in brain research.

[10]  N. Andreasen,et al.  MRI abnormalities in tardive dyskinesia , 1988, Psychiatry Research: Neuroimaging.

[11]  Nancy C. Andreasen,et al.  Problems with ratio and proportion measures of imaged cerebral structures , 1991, Psychiatry Research: Neuroimaging.

[12]  A. Young,et al.  A Magnetic Resonance Imaging Study of Schizophrenia: Brain Structure and Clinical Symptoms , 1991, British Journal of Psychiatry.

[13]  R. Hales,et al.  J Neuropsychiatry Clin Neurosci , 1992 .

[14]  N C Andreasen,et al.  Image processing for the study of brain structure and function: problems and programs. , 1992, The Journal of neuropsychiatry and clinical neurosciences.

[15]  M S Buchsbaum,et al.  Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[16]  K. Krishnan,et al.  Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations. , 1992, Archives of general psychiatry.

[17]  James C. Ehrhardt,et al.  Subcortical and temporal structures in affective disorder and schizophrenia: A magnetic resonance imaging study , 1992, Biological Psychiatry.

[18]  R. Lewine.  Brain morphology in schizophrenia , 1992 .

[19]  N C Andreasen,et al.  The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. , 1992, Archives of general psychiatry.

[20]  E. Smeraldi,et al.  Increased right caudate nucleus size in obsessive-compulsive disorder: Detection with magnetic resonance imaging , 1992, Psychiatry Research: Neuroimaging.

[21]  R. Buchanan,et al.  Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. , 1992, Archives of general psychiatry.

[22]  B. Peterson,et al.  Reduced basal ganglia volumes in Tourette's syndrome using three‐dimensional reconstruction techniques from magnetic resonance images , 1993, Neurology.

[23]  G. Hynd,et al.  Attention Deficit- Hyperactivity Disorder and Asymmetry of the Caudate Nucleus , 1993, Journal of child neurology.

[24]  D. Jeste,et al.  Parkinsonism in neuroleptic-naive schizophrenic patients. , 1993, The American journal of psychiatry.

[25]  W T Carpenter,et al.  Structural abnormalities in deficit and nondeficit schizophrenia. , 1993, The American journal of psychiatry.

[26]  R. Buchanan,et al.  Basal ganglia pathology in schizophrenia and tardive dyskinesia: an MRI quantitative study. , 1994, The American journal of psychiatry.

[27]  J. Brandt,et al.  Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at‐risk persons , 1994, Neurology.

[28]  J. Rapoport,et al.  Quantitative morphology of the caudate nucleus in attention deficit hyperactivity disorder. , 1994, The American journal of psychiatry.

[29]  J. Lieberman,et al.  Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. , 1994, The American journal of psychiatry.

[30]  J. Asarnow,et al.  Childhood-Onset Schizophrenia , 1994 .

[31]  C. Geula,et al.  Human striatum: Chemoarchitecture of the caudate nucleus, putamen and ventral striatum in health and Alzheimer's disease , 1994, Neuroscience.

[32]  E. Pehek,et al.  Differential Effects of Locally Administered Clozapine and Haloperidol on Dopamine Efflux in the Rat Prefrontal Cortex and Caudate‐Putamen , 1994, Journal of neurochemistry.

[33]  M. Keshavan,et al.  Changes in caudate volume with neuroleptic treatment , 1994, The Lancet.

[34]  S. Marder,et al.  Risperidone in the treatment of schizophrenia. , 1994, The American journal of psychiatry.

[35]  N C Andreasen,et al.  Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects. , 1995, The American journal of psychiatry.

[36]  M Ashtari,et al.  Reduced caudate nucleus volume in obsessive-compulsive disorder. , 1995, Archives of general psychiatry.

[37]  J. Lieberman,et al.  Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients. , 1995, The American journal of psychiatry.

[38]  G. Sedvall,et al.  Recent developments in PET scan imaging of neuroreceptors in schizophrenia. , 1995, The Israel journal of psychiatry and related sciences.

[39]  Cynthia G. Wible,et al.  Caudate, putamen, and globus pallidus volume in schizophrenia: A quantitative MRI study , 1995, Psychiatry Research: Neuroimaging.

[40]  K. Krishnan,et al.  Neuroleptic treatment and caudate plasticity , 1995, The Lancet.

[41]  Manzar Ashtari,et al.  Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine , 1995, The Lancet.

[42]  J N Giedd,et al.  Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment. , 1996, The American journal of psychiatry.

[43]  E P Riley,et al.  A decrease in the size of the basal ganglia in children with fetal alcohol syndrome. , 1996, Alcoholism, clinical and experimental research.

[44]  Caudate nucleus area in drug‐induced parkinsonism , 1996, Acta psychiatrica Scandinavica.

[45]  D R Medoff,et al.  Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. , 1996, The American journal of psychiatry.

[46]  N. Andreasen,et al.  Effect of Antipsychotics on Regional Cerebral Blood Flow Measured with Positron Emission Tomography , 1997, Neuropsychopharmacology.

[47]  N. Andreasen,et al.  The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: Assessment with technetium-99m hexamethyl-propyleneamine oxime single photon emission computed tomography , 1997, Biological Psychiatry.

[48]  J. Pujol,et al.  Magnetic resonance imaging measurement of the caudate nucleus in adolescents with attention-deficit hyperactivity disorder and its relationship with neuropsychological and behavioral measures. , 1997, Archives of neurology.

[49]  451 Change in basal ganglia volume across time in patients with schizophrenia: Effects of atypical vs. Typical neuroleptics , 1997, Schizophrenia Research.

[50]  A. Graybiel.  The basal ganglia and cognitive pattern generators. , 1997, Schizophrenia bulletin.

[51]  T. Lidsky.  Neuropsychiatric implications of basal ganglia dysfunction , 1997, Biological Psychiatry.

[52]  G. Pearlson,et al.  Longitudinal change in basal ganglia volume in patients with Huntington's disease , 1997, Neurology.

[53]  Peter J Ell,et al.  Limbic selectivity of clozapine , 1997, The Lancet.

[54]  M. Flaum,et al.  435 The effecf of cumulative neuroleptic exposure on caudate and putamen volumes , 1997, Schizophrenia Research.

[55]  Dan J Stein,et al.  Magnetic resonance brain imaging in women with obsessive-compulsive disorder and trichotillomania , 1997, Psychiatry Research: Neuroimaging.

[56]  A. Graybiel,et al.  Neurochemical architecture of the human striatum , 1997, The Journal of comparative neurology.

[57]  R. Tamura,et al.  Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. , 1997, The American journal of psychiatry.

[58]  R. Kerwin,et al.  Schizophrenia, psychosis, and the basal ganglia. , 1997, The Psychiatric clinics of North America.

[59]  Philip D. Harvey,et al.  Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task. , 1998, Archives of general psychiatry.

[60]  J. Sweeney,et al.  Decreased caudate volume in neuroleptic-naive psychotic patients. , 1998, The American journal of psychiatry.

[61]  N C Andreasen,et al.  Improving tissue classification in MRI: a three-dimensional multispectral discriminant analysis method with automated training class selection. , 1999, Journal of computer assisted tomography.

[62]  J. Ehrhardt,et al.  Measurement of brain structures with artificial neural networks: two- and three-dimensional applications. , 1999, Radiology.